Overexpression of CD64 on CD14

Area of Science:

• Immunology
• Rheumatology

Background:

• Monocytes are key immune cells in rheumatoid arthritis (RA).
• Different monocyte subsets have distinct roles in RA pathogenesis.
• Cluster of differentiation (CD)64, an Fc receptor, is implicated in inflammatory responses, but its specific role in RA requires further investigation.

Purpose of the Study:

• To investigate the expression of CD64 on monocyte subsets in patients with RA.
• To analyze the correlation between CD64 expression on monocyte subsets and RA disease activity markers, autoimmune response, inflammation, and serum cytokines.

Main Methods:

• Flow cytometry was used to determine the expression of CD64 and other markers (CD40, CD163, CD206, HLA-DR, CD80, CD86) on monocytes and monocyte subsets.
• Expression levels were compared between RA patients and healthy volunteers.
• Correlations were analyzed between CD64 expression and clinical/serological markers of RA.

Main Results:

• CD64 expression was significantly elevated on monocytes and all monocyte subsets in RA patients compared to healthy controls.
• Elevated CD64 expression on CD14++CD16- and CD14++CD16+ monocyte subsets correlated positively with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), and disease activity score 28 (DAS28).
• CD64 expression on CD14++CD16+ monocytes was associated with serum interleukin-6 (IL-6) levels.

Conclusions:

• The study demonstrates elevated expression of CD64 on CD14++CD16- and CD14++CD16+ monocyte subsets in RA patients.
• CD64 expression on these monocyte subsets is associated with RA disease activity and inflammatory markers.